NASDAQ : CGC

Canopy Growth Corporation — Key statistics

Healthcare · Drug Manufacturers - Specialty & Generic · Canada

Last price 0.675 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 284.38M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	281.97M
Enterprise Value	238.63M

Dates

Measure	Value
Earnings Date	Nov 6, 2026
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	423.04M
Shares Outstanding	423.04M
Shares Change (YoY)	+164.44%
Shares Change (QoQ)	+9.68%
Owned by Insiders (%)	0.22%
Owned by Institutions (%)	6.93%
Float	422.10M

Ratios

Measure	Value
PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.36
Forward PS	1.13
PB Ratio	0.58
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Evratios

Measure	Value
EV / Earnings	n/a
EV / Sales	1.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financialposition

Measure	Value
Current Ratio	3.04
Quick Ratio	2.28
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.53

Financialefficiency

Measure	Value
Return on Equity (ROE)	-39.51%
Return on Assets (ROA)	-3.92%
Return on Invested Capital (ROIC)	-10.16%
Return on Capital Employed (ROCE)	-6.72%
Weighted Average Cost of Capital (WACC)	15.00%
Revenue Per Employee	$183,307
Profits Per Employee	-$145,221
Employee Count	1,128
Asset Turnover	0.29
Inventory Turnover	2.09

Taxes

Measure	Value
Income Tax	-279,558
Effective Tax Rate	n/a

Stockprice

Measure	Value
Beta (5Y)	2.37
52-Week Price Change	-47.80%
50-Day Moving Average	0.87
200-Day Moving Average	1.00
Relative Strength Index (RSI)	24.54
Average Volume (20 Days)	2,412,929

Shortselling

Measure	Value
Short Interest	31.64M
Short Previous Month	27.24M
Short % of Shares Out	7.48%
Short % of Float	7.50%
Short Ratio (days to cover)	12.61

Incomestatement

Measure	Value
Revenue	206.77M
Gross Profit	58.97M
Operating Income	-44.32M
Pretax Income	-164.09M
Net Income	-163.81M
EBITDA	-18.38M
EBIT	-44.32M
Loss Per Share	-$0.47

Balancesheet

Measure	Value
Cash & Cash Equivalents	237.87M
Total Debt	195.29M
Net Cash	42.59M
Net Cash Per Share	$0.10
Equity (Book Value)	484.92M
Book Value Per Share	1.15
Working Capital	239.14M

Cashflow

Measure	Value
Operating Cash Flow	-56.18M
Capital Expenditures	-3.41M
Depreciation & Amortization	26.37M
Net Borrowing	-9.02M
Free Cash Flow	-59.59M
FCF Per Share	-$0.14

Margins

Measure	Value
Gross Margin	28.52%
Operating Margin	-21.44%
Pretax Margin	-79.36%
Profit Margin	-79.22%
EBITDA Margin	-8.89%
EBIT Margin	-21.44%
FCF Margin	n/a

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	-164.44%
Shareholder Yield	-164.44%
Earnings Yield	-71.58%
FCF Yield	-21.13%

Analystforecasts

Measure	Value
Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	10.33%
EPS Growth Forecast (3Y)	n/a

Stocksplits

Measure	Value
Last Split Date	Dec 20, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

Measure	Value
Altman Z-Score	-12.91
Piotroski F-Score	4

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a